Psychological effects of the intensified follow-up of the CEAwatch trial after treatment for colorectal cancer by Zhan, Zhuozhao et al.
  
 University of Groningen
Psychological effects of the intensified follow-up of the CEAwatch trial after treatment for
colorectal cancer
Zhan, Zhuozhao; Verberne, Charlotte J.; van den Heuvel, Edwin R.; Grossmann, Irene;





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2017
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Zhan, Z., Verberne, C. J., van den Heuvel, E. R., Grossmann, I., Ranchor, A. V., Wiggers, T., & de Bock,
G. H. (2017). Psychological effects of the intensified follow-up of the CEAwatch trial after treatment for
colorectal cancer. PLoS ONE, 12(9), [e0184740]. https://doi.org/10.1371/journal.pone.0184740
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
RESEARCH ARTICLE
Psychological effects of the intensified follow-
up of the CEAwatch trial after treatment for
colorectal cancer
Zhuozhao Zhan1, Charlotte J. Verberne2, Edwin R. van den Heuvel1,3, Irene Grossmann2,4,
Adelita V. Ranchor5, Theo Wiggers2, Geertruida H. de Bock1*
1 Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen,
The Netherlands, 2 Department of Surgery, University of Groningen, University Medical Center Groningen,
Groningen, The Netherlands, 3 Department of Mathematics and Computer Science, Eindhoven University of
Technology, Eindhoven, The Netherlands, 4 Department of Surgery afd. P, Aarhus University Hospital,
Aarhus, Denmark, 5 Department of Health Sciences, University of Groningen, University Medical Center




The aim of the study was to evaluate psychological effects of the state-of-art intensified fol-
low-up protocol for colorectal cancer patients in the CEAwatch trial.
Method
At two time points during the CEAwatch trial questionnaires regarding patients’ attitude
towards follow-up, patients’ psychological functioning and patients’ experiences and expec-
tations were sent to participants by post. Linear mixed models were fitted to assess the influ-
ences and secular trends of the intensified follow-up on patients’ attitude towards follow-up
and psychological functioning. As secondary outcome, odds ratios were calculated using
ordinal logistic mixed model to compare patients’ experiences to their expectations, as well
as their experiences at two different time points.
Results
No statistical significant effects of the intensified follow-up were found on patients’ attitude
towards the follow-up and psychological functioning variables. Patients had high expecta-
tions of the intensified follow-up and their experiences at the second time point were more
positive compared to the scores at the first time point.
Conclusion
The intensified follow-up protocol posed no adverse effects on patients’ attitude towards fol-
low-up and psychological functioning. In general, patients were more nervous and anxious
at the start of the new follow-up protocol, had high expectations of the new follow-up protocol
and were troubled by the nuisances of the blood sample testing. As they spent more time in
the follow-up and became more adapted to it, the nervousness and anxiety decreased and
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the preference for the frequent blood test became high in replacement of conversations with
the doctors.
Introduction
Recent studies investigating follow-up strategies for colorectal cancer (CRC) patients after treat-
ment have provided favourable evidence for more intensive follow-up protocols using the mea-
surement of serum carcinoembryonic antigen (CEA). It has been shown that intensive follow-up
protocols are associated with higher detection rate of curative recurrences and shorter detection
time compared to a minimal follow-up strategies or less intensive ones [1–4]. In addition, ranging
from non-significant to modest survival benefits have been reported by some studies as well [4–
6]. Nowadays, such intense follow-up scheme has become guidelines for routine practice. [7,8]
The CEAwatch trial [9] is a multicentre randomized controlled trial conducted in the Neth-
erlands between year 2010 and 2012. In this trial, the intensified follow-up protocol adheres
bimonthly CEA measurements in the first three years and trimonthly CEA measurements dur-
ing the fourth and fifth years combined with CT imaging. The control follow-up protocol is
the Dutch care as usual follow-up guideline of which consists every 3–6 months CEA measure-
ment and outpatient clinic visit every six months for the first three years and yearly CEA mea-
surement and outpatient visit during the fourth and fifth year. Compared to the care as usual
follow-up, the trial showed that the recurrences are detected earlier by the intensified follow-
up protocol such that higher proportion of recurrences can be treated with curative intent. [9]
There is however no information with regards to the influences of the intensified follow-up
protocol on the psychological aspects of patients and patients acceptance. Concerns have risen on
the effects of high frequent CEA measurements and with that frequent reminders of the past dis-
ease, and the protocol that includes less frequent outpatient clinic visits and communication of
test results by letters. From an implementation perspective, considering the medical benefits, the
psychological outcomes should be at least comparable with the care as usual follow-up protocol.
The primary objective of the CEAwatch trial was to compare the CEAwatch follow-up
scheme with the care as usual in terms of recurrence rate and detection time for the recur-
rences. Secondary outcomes considered were: quality of life, cost-effectiveness, and patients’
survival. The aim of the here presented analysis was to evaluate the psychological effects of the
intervention follow-up protocol in the CEAwatch trial, including the impact of more frequent
blood sample testing on patients’ psychological burden and worrisome of cancer, and explore
patients’ experiences and expectations of the new follow-up protocol. The null hypothesis was
that the intensified follow-up has no effects on patients’ attitude towards follow-up and psy-
chological functioning. It was expected that a higher measurement frequency might on one
hand give more burden and worries to patients and on the other hand might provide more
reassurance. In addition, it was expected that patients would need time to adjust for the new
follow-up protocol. The primary outcomes of this psychological evaluation study were
patients’ attitude towards the follow-up and their psychological functioning including anxiety
and depression, fear of recurrences and cancer worries. The secondary outcomes were
patients’ experiences and expectations of the intensified follow-up.
Materials and methods
Study design
The assessments of patients’ psychological variables were performed alongside the CEAwatch
trial (Netherlands Trial Register 2182, URL: http://www.trialregister.nl/trialreg/admin/
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rctview.asp?TC=2182, Date Registered: 26-Jan-2010). A detailed description of the trial has
previously been published [9]. The CEAwatch trial is a multi-centre stepped wedge cluster ran-
domized trial (SW-CRT) conducted between 1st October, 2010 and 1st October, 2012 with
eleven participating hospitals from the Netherlands. Patients were recruited during the period
of 1st October, 2010 and 1st July, 2012. The trial was approved by the Medical Ethics Commit-
tee of the University Medical Centre Groningen (METc-UMCG2010.064) on 31st May 2010
and signed local feasibility declaration were obtained from all the local participating centres
(Medical Ethical/Testing Committee of the Martini Ziekenhuis Groningen, Medisch Centrum
Leeuwarden, Nij Smellinghe Drachten, Medisch Spectrum Twente Enschede, Meander Med-
isch Centrum Amersfoort, Jeroen Bosch Ziekenhuis Den Bosch, Albert Schweitzer Ziekenhuis
Dordrecht, Medisch Centrum Haaglanden Den Haag, Gelre Ziekenhuis Apeldoorn, Catharina
Ziekenhuis Eindhoven, and Elisabeth Ziekenhuis Tilburg). The authors confirm that all ongo-
ing and related trials for this drug/intervention have been registered.
SW-CRT is a unidirectional design that allows the intervention to roll-out sequentially for
all clusters of hospitals at different time periods of the trial [10–12]. At the beginning of a
SW-CRT trial, all clusters start under the control and each cluster switches sequentially to the
intervention at prespecified moments. All clusters remain under the intervention after the
switch. The main motivation for adopting the SW-CRT design in the CEAwatch trial was that
the computer aiding system used in the CEAwatch trial required time to be implemented at
each site and SW-CRT provided logistic convenience by the phased introduction of the inter-
vention. [12]
In the CEAwatch trial, hospitals were randomly grouped into five clusters and all clusters
started with the care as usual follow-up protocol. Every three months, one randomly selected
cluster switched from care as usual to intensified follow-up protocol (see Table 1). Written
informed consents were obtained before the switch as required by the Medical Ethical Com-
mittee. During the trial, patients with AJCC stage I–III CRC after curative treatment were
included. Patients who received adjuvant chemotherapy were eligible after cessation of the
adjuvant therapy. CONSORT diagram of the CEAwatch trial is provided in Fig 1.
The intensified follow-up protocol used in the CEAwatch trial adhered to every two months
CEA measurements in the first three years and every three months CEA measurements during
the fourth and fifth years of the follow-up. Evaluation of the rise in CEA was performed and
an additional blood sample was drawn in case of CEA rise above 20% compared to the latest
value, with minimum lower threshold CEA value 2.5 ng/mL. Outpatient clinic visits with
imaging of thorax and abdomen were performed annually during the first three years of the
follow-up. Blood test results (CEA value) including a laboratory form for the next appointment
were sent to patients by automatically generated letters from a computer supporting system
[13]. The care as usual follow-up followed the recommendation in the national guidelines of
the Netherlands. This includes an outpatient clinic visit every six months for the first three
years and annual visit during the fourth and fifth year, liver ultrasound and chest X-ray at each
Table 1. Follow-up schedule over time, according to the stepped wedge cluster-randomized design. At day 1 of every three-monthly period a new
cluster switches from the care as usual protocol (CAU) to the intensified follow-up protocol (CEA). Grey periods 1 and 2 represent the times questionnaires
were sent (1st round September 2011, 2nd round June 2012).
Cluster Oct, 2010 Jan, 2011 Apr, 2011 Jul, 2011 1 Oct, 2011 Jan, 2012 2
1 CAU CEA CEA CEA CEA CEA
2 CAU CAU CEA CEA CEA CEA
3 CAU CAU CAU CEA CEA CEA
4 CAU CAU CAU CAU CEA CEA
5 CAU CAU CAU CAU CAU CEA
https://doi.org/10.1371/journal.pone.0184740.t001
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clinic visit, CEA measurements every 3–6 months for the first three years and once a year mea-
surements during the fourth and fifth year.
Data collection and questionnaires
The psychological effects of the follow-up protocol were evaluated by questionnaires sent
by post. As it was not permitted to collect data prior to the obtainment of the feasibility dec-
laration from the local centre per requirement of the primary ethical committee, it was not
possible to send out questionnaires while all clusters were exposed to the control follow-up
protocol. Therefore, at two time points during the trial, patients were asked to fill in the ques-
tionnaires. The first time points was September 2011, after three of the five clusters (6 of the 11
hospitals) had already switched to the intensified follow-up and the other two clusters were
still in the care as usual follow-up. The second time point was June 2012, when all clusters had
crossed over to the intensified follow-up and all patients had experienced the intensified fol-
low-up (see Table 1). This had consequences of having different time between adopting inten-
sified follow-up protocol and the psychological assessment. The durations of experiencing the
new intensified follow-up protocols for patients from different clusters varied.
The questionnaires consisted of four sections: attitude towards follow-up, psychological
functioning, experiences and expectations and sociodemographic data. Other disease-
specific information, such as primary tumor stage, was retrieved from the CEAwatch trial.
Fig 1. Consort diagram of the CEAwatch trial.
https://doi.org/10.1371/journal.pone.0184740.g001
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Attitude towards follow-up. Patients’ attitude towards the follow-up was measured by a
validated 16-item questionnaire previously developed to assess routine follow-up of colorectal
cancer [14]. The questionnaire consisted of four subscales: reassurance, nervous anticipation,
perceived disadvantages of the follow-up and communication (with physicians). All items
were measured with Likert scales ranging from 1 to 4. Items belonging to the same subscales
were combined to derive a single sum scores for each subscale, respectively. For reassurance
and communication, higher scores corresponded to more positive responses, while higher
score corresponded to more negative responses for nervous anticipation and perceived
disadvantages.
Psychological functioning. The fear of recurrence was assessed by a 6-item questionnaire.
From the original 3-item questionnaire used by several former studies [14,15], this instrument
was extended so that it is more tailored to the trial. The English translation of the added three
items can be found in Table 2. Outcomes were measured with the sum scores of the 6 items
ranging from 6 to 24. A higher score indicates stronger fear. The original 3-item questionnaire
had a Cronbach’s alpha of 0.75.[14] The extended version used in the present study also had
high reliability (Cronbach’s alpha: 0.80) based on the current data. In addition, cancer worries
were examined using the Dutch version of the validated Cancer Worry Scale [16–18], with
each item using a 4-point Likert scale ranging from “never” to “almost always”. General anxi-
ety and depression were examined by the Dutch version of the Hospital Anxiety and Depres-
sion Scale (HADS) [19]. It consisted of 14 items with 7 items for anxiety (ranging from 0 to
21) and 7 items for depression (ranging from 0 to 21). Within the HADS, a higher score meant
more anxiety and depression respectively.
Experiences and expectations. For this part, a self-developed questionnaire was used.
Patients were asked to complete 15 questions about their experiences during the intensified
follow-up. If patients were still in the care as usual follow-up and had no experiences about the
intensified follow-up, they were asked to answer the same 15 questions about the intensified
follow-up to compare their expectations to the experiences. A 5-point Likert scale ranging
from 1 to 5 was used for these items. These 15 questions are listed in Table 3.
Statistical analyses
The outcomes on the eight subscales, namely reassurance, nervous anticipations, disadvan-
tages, communications, HADS anxiety, HADS, depression, cancer worry scores, and fear of
recurrences, were considered as the primary outcomes. Patients’ expectations and experiences
were considered as secondary outcomes.
The aforementioned SW-CRT design required special attention of the secular trends in the
analysis of the questionnaire data. Considering the nested structure of the design, a linear
mixed model was used to assess the effects of the intensified follow-up on patients’ attitude
towards the follow-up and their psychological function corrected for the secular trends. Each
Table 2. Extended questionnaires for the fear of recurrence.
Item Scale
Original Do you feel insecure about your health? Not at all–Very
muchDo you think the disease might still recur?
Do you feel completely cured?
Extension Do you feel that the disease will certainly come back to your bowel?
Are you afraid that the disease will come back somewhere else than the
bowel?
If possible, would you prefer to go to a specialist nurses?
https://doi.org/10.1371/journal.pone.0184740.t002
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primary outcome was considered separately as the dependent variable in the linear mixed
model. To be more specific, for each dependent variable, three types of effects were assumed,
namely the time effect, the treatment effect and the differences between patients who switched
from control to intervention and those who experienced intervention only for both measure-
ment rounds. Time effect was estimated by contrasting second time measurements to the first
time measurements within the group of patients who only had intervention for both rounds.
Differences between the two groups of patients were assessed by comparing the two groups at
the second time point. The treatment effect was estimated by contrasting two treatment groups
(intensified CEA compared to CaU) at the first time but correcting for the differences between
patients. The psychological effects of the follow-up protocol were also corrected for age, gender
Table 3. Questionnaires regarding patients’ experiences of the intensified follow-up protocol.
 More Positive More Negative!
1) I am satisfied with the current
follow-up
Totally agree Agree I don’t
know
Somewhat disagree Completely disagree









Somewhat stressful Very stressful
4) Bimonthly check of my blood
reassures me
Totally agree Agree I don’t
know
Somewhat disagree Completely disagree
5) I would like my blood checked
every two months
Totally agree Agree I don’t
know
Somewhat disagree Completely disagree
6) Transportation for intensified













8) I find results send by letters very
pleasant
Very pleasant Pleasant I don’t
know
Somewhat annoying Very annoying
9) Knowing the dates of the blood







10) I think waiting a week for the






11) I think having a conversation with
the doctor during visit is:
Very important Important I don’t
know
Somewhat unimportant Completely unimportant
12) I think frequent testing for early
detection of metastases is more
important than a conversation with
the doctor
Totally agree Agree I don’t
know
Somewhat disagree Completely disagree
13) Having a conversation with the
doctor once a year would be enough
for me
Totally agree Agree I don’t
know
Somewhat disagree Completely disagree
14) I would like to know if I have a
metastasis, even though I’m aware
this cannot be treated for months
and I have no complaints
Totally agree Agree I don’t
know
Somewhat disagree Completely disagree
15) I find it hard to cope with the
uncertainty that the follow-up cannot







§ The order of the options were deliberately reversed compared to the original questionnaire sent to patients so that OR>1 always indicates higher
probability of being more positive.
https://doi.org/10.1371/journal.pone.0184740.t003
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and tumor stage. Outcomes from two measurement time points were modeled as bivariate
normal and hospital was considered as a random effect. (Details about the linear mixed model
can be found in S1.) The p-values of the hypothesis test were adjusted for multiplicity of testing
several primary outcomes [20] using the Hochberg method [21]. Since patients’ scores were
not normally distributed within the attitude and psychological functioning dimensions, sensi-
tivity analysis was conducted. These outcomes were reanalyzed with proper transformation of
the outcome, namely logarithm and square root transformations. To keep the interpretation of
the results simple and straightforward, the results of the linear mixed model were reported
unless the sensitivity analysis would demonstrate a contradiction in conclusions. In that case,
the results of the sensitivity analysis were reported instead.
To evaluate patients’ experiences and expectations of the intensified follow-up, an ordinal
logistical mixed model with cumulative logit link function was applied and odds ratios were
calculated for two comparisons. The first comparison is between patients’ experiences and
their expectations corrected for the temporal effect. The second one is between patients’ expe-
riences measured at the 2nd time point and the experiences measured at the 1st time point. The
model was also adjusted for patients’ age, gender and the tumor stage. Factor analysis sug-
gested no satisfying structural relationships among these 15 items by examining the Scree plot.
Thus, the analysis was done item by item. No adjustment for multiple comparisons were made
for this secondary outcome.[20]. Only the odds ratios between experiences and expectations,
as well as the odds ratios of experiences between the two time points, were presented in the
result section.
If patients did not complete at least 80% of the items within certain subscales or dimen-
sions, the score of this subscale/dimension was considered missing. Missing data was consid-
ered to be missing at random (MAR) and no special treatment for missing data was needed
since inferences with maximum likelihood (used in both the linear and generalized mixed
models) are still valid under this assumption. Statistical analyses were performed with SAS1
statistical software, version 9.4. Linear mixed models were fitted using PROC MIXED and gen-
eralized linear mixed models were fitted using PROC GLIMMIX.
Results
Patient characteristics and response rate
On November 1st, 2011, total of 2,016 patients participated in the CEAwatch trial, and
received the questionnaires. A total of 1,591 patients (78.9%) returned the questionnaires. On
May 1st, 2012, total of 1,848 patients participated in the CEAwatch trial, 1556 (84.2%) of them
returned the questionnaires. Patient characteristics of the two rounds are given in Table 4.
During the first round, 820 (51.6%) of them participated in the care as usual follow-up and 770
(48.4%) were in the intensified follow-up (1 missing). At second round, all patients (2 missing)
were in the intensified follow-up (Table 4). Among all patients, 1162 of them participated in
both rounds of questionnaires. Summary of patients’ experiences and expectations question-
naire is available in S1 Table.
Primary outcomes. The estimations for the psychological effects on patients’ attitude
towards follow-up and psychological functioning of the intensified follow-up protocol and
time periods differences are shown in Table 5. No statistical significant effects of the intensified
follow-up were found on patients’ attitude towards the follow-up. Furthermore, there were no
significant differences on anxiety and depression, fear of recurrences and cancer worries
between the intensified follow-up protocol and care as usual follow-up. Comparing between
two time points, no statistically significant temporal differences were found for all subscales.
Psychological effects of the intensified follow-up of the CEAwatch trial
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Secondary outcomes. The comparisons between patients’ experiences and expectations
are shown in Fig 2. In general, comparing patients’ experiences in the intensified follow-up to
their expectations, the responses were towards the negative end of the spectrum. Particularly,
patients expressed that the stress of the blood test was higher than they expected (OR: 0.10,
95% CL: [0.06, 0.16], p-value: <0.001) while they were less reassured by it (OR: 0.35, 95% CL:
[0.24, 0.52], p-value:<0.001) and the preferences of the blood tests were not in favour of the
intensified follow-up (OR: 0.22, 95% CL: [0.15, 0.33], p-value:<0.001). In addition, the incon-
veniences of the blood tests such as transportations (OR: 0.28, 95% CL: [0.14, 0.55], p-value:
0.0003), waiting time to turn in a blood sample (OR: 0.10, 95% CL: [0.06, 0.18], p-value:<
0.001) and results sent by letters (OR: 0.04, 95% CL: [0.02, 0.06], p-value: <0.001) were less
appreciated.
In the comparisons between patients’ second experiences and their first time experiences,
the responses at the second time were more positive than the one at the first time as shown in
Fig 3. At the second time points, patients had statistically significant higher probability to give
a more positive response. Specifically, patients were more positive about all the items that did
not meet with expectations in the previous comparison. Blood tests were less stressful (OR:
5.28, 95% CL: [3.91, 7.13], p-value: <0.001) and provided more reassurance (OR: 2.12, 95%
CL: [1.66, 2.71], p-value: <0.001) at the second time point compared to their first time experi-
ences. Preferences of the blood test became higher (OR: 2.75, 95% CL: [2.14, 3.52], p-value:<
0.001) and the frequent tests were more preferred in replacement of having conversation with
Table 4. Patient characteristics and summary of primary outcome scores for the first round and sec-
ond round evaluations.
Round 1 (n = 1591) Round 2 (n = 1556)
Age: median (range) 68 (26–94) 68 (29–93)
AJCC stage1
I 422 (27.80%) 433 (29.94%)
II 595 (39.20%) 572 (39.56%)
III 501 (33.00%) 441 (30.50%)
Gender2
Female 685 (43.11%) 621 (40.01%)
Male 904 (56.89%) 931 (59.99%)
CEA follow-up3
Intervention 770 (48.43%) 1554 (100.00%)
Control 820 (51.57%) 0 (0.00%)
Attitude towards follow-up median (range) median (range)
Reassurance 13 (4–16) 13 (4–16)
Nervous anticipation 7 (5–20) 7 (5–18)
Perceived disadvantages 4 (3–11) 4 (3–11)
Communication 13 (4–16) 13 (4–16)
Psychological functioning median (range) median (range)
Fear of recurrence 12 (6–24) 12 (6–22)
HADS: Anxiety 3 (0–21) 3 (0–21)
HADS: Depression 2 (0–20) 1 (0–20)
Cancer worries 13 (8–31) 13 (8–31)
1 Missing 73 for round 1 and missing 110 for round 2
2 Missing 2 for round 1 and missing 4 for round 2
3 Missing 1 for round 1 and missing 2 for round2.
https://doi.org/10.1371/journal.pone.0184740.t004
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the doctors (OR: 1.89, 95% CL: [1.49, 2.41], p-value:<0.001). Satisfaction of yearly conversa-
tion with the doctors became higher as well (OR: 1.75, 95% CL: [1.40, 2.18]. p-value:<0.001)
with the importance of the conversation with the doctors decreased (OR: 0.70, 95% CL: [0.52,
0.95]. p-value: 0.02). Furthermore, patients felt easier coping with uncertainties of the test
(OR: 1.32, 95% CL: [1.03, 1.71], p-value: 0.03)
Table 5. Estimates and 95% confidence limits of follow-up protocol effects and secular trends from linear mixed model for patients’ attitude
towards the follow-up and psychological functioning.
Intensified follow-up vs. care as usual Time trends
Estimates 95% CL Adjusted p-value* Estimates 95% CL Adjusted p-value*
Reassurance 0.1202 -0.4504 0.6909 0.64 -0.2347 -0.5310 0.0617 0.42
Nervous anticipation 0.5738 -0.2669 1.4146 0.64 -0.5423 -0.9690 -0.1156 0.12
Perceived disadvantage 0.2544 -0.2815 0.7904 0.64 -0.2153 -0.4880 0.0574 0.42
Communication 0.2365 -0.5618 1.0348 0.64 -0.3121 -0.7211 0.0967 0.42
HADS: Anxiety 0.6135 -0.0490 1.2759 0.56 -0.4348 -0.7925 -0.0771 0.12
HADS: Depression 0.3258 -0.4189 1.0706 0.64 -0.1461 -0.5319 0.2396 0.42
Cancer worries 0.2510 -0.7325 1.2346 0.64 -0.2275 -0.7319 0.2768 0.42
Fear of recurrence 0.2229 -0.8381 1.2838 0.64 -0.2264 -0.7651 0.3122 0.42
* Adjusted p-values were calculated according to the Hochberg method for multiple comparison adjustment.
https://doi.org/10.1371/journal.pone.0184740.t005
Fig 2. Patients experiences of the intensified follow-up compared to their expectations.
https://doi.org/10.1371/journal.pone.0184740.g002
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Sensitivity analysis. The hypothesis tests of the linear mixed model could be affected by
the skewed residual of the data. For reassurance subscale, the conditional residual was nega-
tively skewed and the dependent variable itself was first converted to positive skewness and
then logarithm-transformed. The estimations after the transformation (both treatment effect
and time effect) were more towards the null and were consistent with the estimations of the
linear mixed model. For nervous anticipation and cancer worry subscale, direct logarithm
transformations were applied respectively. The treatment effect remained non-significant and
the time effect remained significant for nervous anticipation. Both effects were shifted towards
the null for cancer worry subscale. For both HADS subscales, square root transformations
were used and the results remained the same. The rest of the subscales were normally distrib-
uted. Detailed sensitivity analysis results are available in the S2 Table. To conclude, the results
of the sensitivity analysis agreed with the linear mixed model and the estimations presented
were accurate enough to be clinically meaningful.
Discussion
In the CEAwatch trial, an intensified follow-up protocol was compared to the Dutch care as
usual follow-up guideline. The major differences in the intensified follow-up protocol relevant
to the discussion of the present study was that the frequency of outpatient clinic visit during
the first three years of the follow-up were reduced and in replacement was a more intensive
CEA measurements scheme.
The effects of the intensified follow-up protocol for CRC patients after surgery in the CEA-
watch trial were evaluated with regards to patients’ psychological variables. No statistical
significant effects were found on patients’ attitude towards the follow-up and psychological
functioning. For patients’ psychological functioning, no proof of increased burden or im-
provement was observed comparing the intensified follow-up protocol to the care as usual fol-
low-up protocol.
Comparisons between patients’ experiences and expectations resulted in more negative
responses for patients’ experiences which indicate that the expectations of the new follow-up
protocols were high. On the other hand, by analysing the experiences at two different time
points, we found that the responses became more positive later in time. Especially, patients
responded more positively to blood test including reassurance, stressfulness and preference.
This is in accordance with the results from the primary outcome that no decrease in reassur-
ance were observed since it has been shown that patients are reassured by outpatient clinic vis-
its and having conversation with the doctors [14]. From the present study, one may deduce
that the frequent blood test compensated for less frequent clinic visit in the intensified follow-
up protocol in terms of reassurance. In addition, patients’ responses to the inconveniences of
the blood tests were improved with time as well.
It has been mentioned that follow-up may remind patients of their cancers and possible
relapsing of malignant disease [14]. However, even with more frequent blood tests, patients’
cancer worries and fear of recurrences did not increase, nor did the HADS anxiety scores.,
Though it is expected that patients were more nervous and anxious about the new follow-up
protocol as they were inexperienced with this new strategy, no significant differences were
found between the earlier assessment time point and the later time point. On the other hand,
from the exploratory analysis results of patients’ experiences and expectations, it was indicated
that patients’ preferences with the proposed intensified follow-up protocol increased as they
became more familiar with the protocol.Currently, limited information is available regarding
the impact of follow-up protocols on patients’ quality of life and psychological functioning
[14,22] from the literature. The FACS study also planned to investigate the quality of life and
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satisfaction of care of the colorectal cancer follow-up and the results have not been published
yet. The presented study with large sample size and high response rate, provided such informa-
tion for the state-of-art post-treatment follow-up protocol. It should be noted that the statisti-
cal method used in the present study explicitly assumed no treatment-period interaction. In
case treatment-period interaction was present, the estimator would be biased and could lead
to an opposite conclusion on treatment effect. Thus our results should be viewed under the
assumption of no treatment-period interaction effect. Due to the restricted policies from the
medical ethical committee and the required time for collecting questionnaires by post, collecting
data from more periods was infeasible. As such, it prohibits the possibility to investigate and ver-
ify the assumption of no treatment-period interaction which we originally planned for. Mean-
while, the results of the secondary outcome should be interpreted with caution since for this
study relevant questions were formulated and these were analyzed item by item. The purpose
was to provide a qualitative insight in patient’s expectations and experience, tailored to the fea-
tures of the intensified follow-up protocols used in the CEAwatch trial. In our opinion, it is suffi-
cient enough to provide indirect evidence on the general trends of patients’ experiences with
regards to the intensified follow-up and is in agreement with the primary outcomes. In addition,
doubts have been raised as to the validity of the HADS. It is recommended not to use this instru-
ment anymore for future study. However, the questionnaires were already used by then.
In conclusion, the intensified follow-up protocol posed no adverse effects on patients’ atti-
tude towards the follow-up and psychological functioning. In general, patients had high
Fig 3. Patients’ 2nd time experiences of the intensified follow-up compared to their 1st time experiences.
https://doi.org/10.1371/journal.pone.0184740.g003
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expectations of the new follow-up protocol and were troubled by the nuisances of the blood
sample testing at the start of the new follow-up protocol. As they spent more time in the fol-
low-up and became more adapted to it, the preference for the frequent blood test became high
in replacement of conversations with the doctors.
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